SEC exempt reporting adviser · Early stage
CKG MANAGEMENT
CKG Management administers documentation for collective private investments by accredited investors, focused on early-stage biotech and pharma companies. It also offers advisory and fractional CFO/COO services.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is CKG MANAGEMENT right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds CKG MANAGEMENT joined, from press and the firm’s own posts.
Every round CKG MANAGEMENT joined
Round sizes, CKG MANAGEMENT’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company CKG MANAGEMENT backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet CKG MANAGEMENT
Events where CKG MANAGEMENT’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
CKG MANAGEMENT is based in the United States.
7 fund vehicles are on public registers (SEC adviser filings), including R4JV, LLC, NT3JV, LLC and R2JV, LLC.
Stages: Early stage. Sectors: Biotech. From the firm’s own website.
CKG MANAGEMENT lists 4 portfolio companies on its website: CAGE Bio, Nanoscope Therapeutics, OncoNano Medicine and Renibus Therapeutics.
Firms whose websites list some of the same companies include Bios Partners.
Know before CKG MANAGEMENT’s next round is announced.
PRO tracks CKG MANAGEMENT’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.